GlassScriptPhysician profile
Dawn D Wells
NPI 1275753956
$5,755.86
in general payments reported to CMS, 2019-2025
24 companies · $1,608 in 2025
The $1,608 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $309 · 2022: $1,638 · 2023: $983 · 2024: $1,218 · 2025: $1,608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,602 · Education: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,601.66 |
| Education | $207.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,509.66 | 2021-2025 | |
| Amgen INC. | $673.18 | 2021-2025 | Otezla, Otezla |
| Pfizer INC. | $481.57 | 2022-2025 | |
| Incyte Corporation | $442.52 | 2021-2025 | Opzelura, Opzelura |
| Janssen Biotech, INC. | $391.48 | 2023-2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $248.33 | 2022-2025 | Sotyktu |
| Lilly USA, LLC | $234.09 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Arcutis Biotherapeutics, INC. | $230.27 | 2023-2025 | Zoryve |
| Galderma Laboratories, L.P. | $222.95 | 2022-2025 | Epsolay, Aklief, Oracea |
| Ucb, INC. | $212.15 | 2021-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $193.33 | 2022-2025 | Libtayo, Dupixent |
| Novartis Pharmaceuticals Corporation | $179.62 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $177.51 | 2021-2023 | Absorica Ld, Winlevi, Blu-U |
| Genzyme Corporation | $129.43 | 2022-2024 | |
| Leo Pharma INC. | $123.79 | 2022-2025 | Adbry, Anzupgo |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $91.68 | 2022-2025 | Seysara, Klisyri |
| Journey Medical Corporation | $58.36 | 2022-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $37.88 | 2022-2023 | Siliq |
| Botanix Sb INC | $25.26 | 2025 | Sofdra |
| Tempus Ai, INC | $24.35 | 2024 | Merlin Test |
| Fidia Pharma USA INC. | $19.65 | 2025 | |
| Mayne Pharma Commercial LLC | $16.66 | 2021 | |
| Cipher Pharmaceuticals US LLC | $16.24 | 2025 | Natroba, Spinosad |
| Biofrontera INC. | $15.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.